Spain Digestive System Disorder Medicine Sales is set to reach $3,830 Million by 2026 from $3,370 Million, is expected to rise 7.7% per year. Since 2017, the market was up 3.9% year on year totalising $36,680 Million. Japan, South Korea and Canada respectively were numbers 2, 3 and 4 in this ranking.
How does Spain perform in Digestive System Disorder?
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Spain
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use in Spain
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Spain
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Spain
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Spain
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Spain
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Spain
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Spain
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Spain
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Spain
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research